BRPI0917377A2 - processo para a preparacao de (1s,2r)-3-[[(4-aminofenil) sulfonil] (isobutil) amino]-1-benzil-2-hidroxipropilcarbamato de (3r,3as,6ar)-hexahidrofuro[2,3-b] furan-3-ila - Google Patents

processo para a preparacao de (1s,2r)-3-[[(4-aminofenil) sulfonil] (isobutil) amino]-1-benzil-2-hidroxipropilcarbamato de (3r,3as,6ar)-hexahidrofuro[2,3-b] furan-3-ila

Info

Publication number
BRPI0917377A2
BRPI0917377A2 BRPI0917377A BRPI0917377A BRPI0917377A2 BR PI0917377 A2 BRPI0917377 A2 BR PI0917377A2 BR PI0917377 A BRPI0917377 A BR PI0917377A BR PI0917377 A BRPI0917377 A BR PI0917377A BR PI0917377 A2 BRPI0917377 A2 BR PI0917377A2
Authority
BR
Brazil
Prior art keywords
hexahydrofuro
ila
aminophenyl
furan
sulfonyl
Prior art date
Application number
BRPI0917377A
Other languages
English (en)
Inventor
Dominique Louis Nestor Ghislain Surleraux
Herman Augustinus De Kock
Piet Tom Bert Paul Wigerinck
Wim Albert Alex Aelterman
Wim Gaston Verschueren
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40786641&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0917377(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of BRPI0917377A2 publication Critical patent/BRPI0917377A2/pt
Publication of BRPI0917377B1 publication Critical patent/BRPI0917377B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
BRPI0917377-3A 2008-09-01 2009-09-01 Processo para a preparação de (1s,2r)-3-[[(4-aminofenil) sulfonil] (isobutil) amino]-1-benzil-2- hidroxipropilcarbamato de (3r,3as,6ar)-hexahidrofuro[2,3-b] furan-3-ila e compostos intermediários BRPI0917377B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08163383 2008-09-01
EP08163383.6 2008-09-01
PCT/EP2009/061253 WO2010023322A1 (en) 2008-09-01 2009-09-01 Process for the preparation of (3r,3as,6ar)-hexahydrofuro [2,3-b] furan-3-yl (1s,2r)-3-[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate

Publications (2)

Publication Number Publication Date
BRPI0917377A2 true BRPI0917377A2 (pt) 2015-12-01
BRPI0917377B1 BRPI0917377B1 (pt) 2022-04-19

Family

ID=40786641

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0917377-3A BRPI0917377B1 (pt) 2008-09-01 2009-09-01 Processo para a preparação de (1s,2r)-3-[[(4-aminofenil) sulfonil] (isobutil) amino]-1-benzil-2- hidroxipropilcarbamato de (3r,3as,6ar)-hexahidrofuro[2,3-b] furan-3-ila e compostos intermediários

Country Status (12)

Country Link
US (1) US8580981B2 (pt)
EP (1) EP2346877B1 (pt)
JP (1) JP5498497B2 (pt)
CN (1) CN102131815B (pt)
AR (3) AR073248A1 (pt)
AU (1) AU2009286619B2 (pt)
BR (1) BRPI0917377B1 (pt)
CA (1) CA2734814C (pt)
ES (1) ES2519115T3 (pt)
MX (1) MX2011002259A (pt)
TW (1) TWI482775B (pt)
WO (1) WO2010023322A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8921415B2 (en) 2009-01-29 2014-12-30 Mapi Pharma Ltd. Polymorphs of darunavir
BR112012009956A2 (pt) 2009-10-30 2015-09-29 Lupin Ltd um novo processo para a preparação de darunavir e etanolato darunavir de tamanho de partícula.
WO2011092687A1 (en) 2010-01-28 2011-08-04 Mapi Pharma Hk Limited Process for the preparation of darunavir and darunavir intermediates
CN102584844B (zh) * 2011-01-11 2016-04-13 浙江九洲药业股份有限公司 一种达芦那韦晶型及其制备方法
CN102617586B (zh) * 2011-01-26 2016-04-06 浙江九洲药业股份有限公司 地瑞那韦中间体的制备方法
WO2013011485A1 (en) 2011-07-20 2013-01-24 Ranbaxy Laboratories Limited Process for the preparation of sulfonamides useful as retroviral protease inhibitors
ES2969589T3 (es) 2012-07-24 2024-05-21 Laurus Labs Ltd Solvato de Propionato de Darunavir
CN105315178B (zh) * 2014-07-09 2018-07-06 浙江九洲药业股份有限公司 达芦那韦相关物质及其制备方法
JP6435907B2 (ja) * 2015-02-16 2018-12-12 住友化学株式会社 ヘキサヒドロフロフラノール誘導体の製造方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968942A (en) 1992-08-25 1999-10-19 G. D. Searle & Co. α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
ATE174587T1 (de) 1993-08-24 1999-01-15 Searle & Co Hydroxyaminosulfonamide verwendbar als inhibitoren retroviraler proteasen
CN1091088C (zh) 1995-02-03 2002-09-18 钟渊化学工业株式会社 α－卤代酮、α－卤代醇和环氧化物的制备方法
DE69711395T2 (de) 1996-08-23 2002-11-07 Gilead Sciences Inc Verfahren zur herstellung von cyclohexen-carboxylatderivate
GB9805898D0 (en) 1998-03-20 1998-05-13 Glaxo Group Ltd Process for the sythesis of hiv protease inhibitors
AU4828199A (en) 1998-06-23 2000-01-10 Board Of Trustees Of The University Of Illinois, The Multi-drug resistant retroviral protease inhibitors and associated methods
CA2336160C (en) 1998-06-23 2015-02-17 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Use of compounds for treating hiv
DE69918050T2 (de) 1998-08-25 2005-06-30 Kaneka Corp. Verfahren zur herstellung von (2r,3s)-3-amino-1,2-oxiran
WO2000044736A1 (fr) 1999-01-29 2000-08-03 Kaneka Corporation PROCEDE DE PREPARATION DE DERIVES DE threo-1,2-EPOXY-3-AMINO-4-PHENYLBUTANE
KR100708221B1 (ko) 1999-08-31 2007-04-17 아지노모토 가부시키가이샤 에폭사이드 결정의 제조방법
US6455738B1 (en) 2000-07-13 2002-09-24 Rhodia Chimie Process for the sulfonation of an aromatic compound
US6764545B2 (en) 2000-12-12 2004-07-20 Ajinomoto Co., Inc. Production method of epoxide crystal
JP4521185B2 (ja) 2001-09-10 2010-08-11 テイボテク・フアーマシユーチカルズ・リミテツド ヘキサヒドロ−フロ［２，３−ｂ］フラン−３−オールの製造法
CA2472133A1 (en) 2001-12-28 2003-07-17 Ajinomoto Co., Inc. Process for producing crystal of benzenesulfonamide derivative, and novel crystal of intermediate therefor and process for producing the same
AU2003271740B2 (en) 2002-05-16 2010-05-13 Janssen R&D Ireland Pseudopolymorphic forms of a HIV protease inhibitor
MXPA05001792A (es) 2002-08-14 2005-04-25 Tibotec Pharm Ltd Oxindolsulfonamida sustituida como inhibidores de proteasa de virus de inmunodeficiencia humana de amplio espectro.
CA2549460C (en) * 2003-12-23 2014-08-05 Tibotec Pharmaceuticals Ltd. Process for the preparation of (3r,3as,6ar)-hexahydrofuro [2,3-b] furan-3-yl (1s,2r)-3-[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate
RS51073B (sr) * 2003-12-23 2010-10-31 Tibotec Pharmaceuticals Ltd. Proces za pripremanje (3r,3as,6ar)-heksahidrofuro│2,3-b│ furan-3-il (1s,2r)-3-││(4-aminofenil) sulfonil│(izobutil) amino │-1-benzil-2-hidroksipropilkarbamata
CN1953964A (zh) 2004-03-11 2007-04-25 塞阔伊亚药品公司 抗耐药性反转录病毒蛋白酶抑制剂
CN1997363B (zh) 2004-05-07 2012-03-28 塞阔伊亚药品公司 抗耐药性反转录病毒蛋白酶抑制剂
AR058238A1 (es) 2005-11-28 2008-01-23 Tibotec Pharm Ltd Compuestos y derivados de aminofenilsulfonamida sustituida como inhibidores de proteasa del vih
TWI385173B (zh) 2005-11-28 2013-02-11 Tibotec Pharm Ltd 作為ｈｉｖ蛋白酶抑制劑之經取代的胺基苯基磺醯胺化合物

Also Published As

Publication number Publication date
CA2734814C (en) 2017-03-07
AU2009286619B2 (en) 2015-05-14
AR073248A1 (es) 2010-10-20
AU2009286619A1 (en) 2010-03-04
TW201022276A (en) 2010-06-16
BRPI0917377B1 (pt) 2022-04-19
EP2346877B1 (en) 2014-08-20
MX2011002259A (es) 2011-04-12
US20110160468A1 (en) 2011-06-30
WO2010023322A1 (en) 2010-03-04
EP2346877A1 (en) 2011-07-27
TWI482775B (zh) 2015-05-01
AR118270A2 (es) 2021-09-22
CA2734814A1 (en) 2010-03-04
US8580981B2 (en) 2013-11-12
JP2012501316A (ja) 2012-01-19
CN102131815B (zh) 2014-10-15
AR119702A2 (es) 2022-01-05
ES2519115T3 (es) 2014-11-06
JP5498497B2 (ja) 2014-05-21
CN102131815A (zh) 2011-07-20

Similar Documents

Publication Publication Date Title
BRPI0917377A2 (pt) processo para a preparacao de (1s,2r)-3-[[(4-aminofenil) sulfonil] (isobutil) amino]-1-benzil-2-hidroxipropilcarbamato de (3r,3as,6ar)-hexahidrofuro[2,3-b] furan-3-ila
IL211191A (en) Oxalate salt of (3as, 4r, 6s, 6ar) –6– (2– hydroxyethoxy) –2,2 – dimethyl tetrahydro –3 ah– cyclopenta [d] [1,3] dioxol – 4 – amine
BRPI0718706B8 (pt) métodos para a preparação de hexa-hidrofuro[2,3- b]furan-3-ol
ME01059B (me) Proces za pripremanje (3r,3as,6ar)-heksahidrofuro [2,3-b] furan-3-il (1s,2r)-3-[[(4-aminofenil) sulfonil] (izobutil) amino]-1-benzil-2- hidroksipropilkarbamata
BRPI0815507A2 (pt) Espectrômetro para fundo do furo por arranjo de diodo laser
BRPI0819631A2 (pt) Processo para a preparação de um produto olefínico
IL194122A (en) Process for making (6ar, 3as, 3r) hexahydroporo [3,2– b] furan – 3 – val
BRPI0812146A2 (pt) Processo, mistura, utilização da mistura, borracha sintética
BRPI0819552A2 (pt) Processo para produzir um polímero a base de olefina
SI1732931T1 (sl) Postopki priprave spojine (3r,3as,6ar) heksahidro-furo(2,3-b)furan-3-ol
FR2927026B1 (fr) Poste de pilotage d'un vehicule
BRPI0417272B8 (pt) processo para a preparação de (3r, 3as, 6ar)-hexahidrofuro [2,3-b] furan-3-il (1s, 2r)-3-[[(4-aminofenil) sulfonil] (isobutil) amino]-1-benzil-2-hidroxipropilcarbamato
BR112012009956A2 (pt) um novo processo para a preparação de darunavir e etanolato darunavir de tamanho de partícula.
EE00623U1 (et) Pudeli sulgur
EP3313847A4 (en) PROCESS FOR PREPARING (3R, 3AS, 6AR) HEXAHYDROFURO [2,3-B] FURAN-3-YL ESTER OF [(1S, 2R) -3 - [[(4-AMINOPHENYL) SULFONYL] (2-METHYLPROPYL) ACID ) AMINO] -2-HYDROXY-1- (PHENYLMETHYL) PROPYL] -CARBAMIC AND ITS AMORPHOUS FORM
EE00592U1 (et) Pudeli sulgur
HK1195307A1 (zh) -羥基- -二甲基四氫- -環戊二烯並 二氧戊環- -基 氨基甲酸苄酯的製備方法和該方法中的中間體
ITMI20051293A1 (it) Procedimento per lo staccaggio di zolfo effdettuato mediante blocchi di zolfo
BRPI0917519A2 (pt) Processo para preparacao de um polimorfo de 7-cloro-n,n,5-trimetil-4-oxo-3-fenil-3,5-di-hidro-4h-pir idazino[4,5-b]indol-1-acetamida
LT2643326T (lt) (3r,3as,6ar)-heksahidrofuro[2,3-b]furan-3-olio gavimo būdas
WO2010151476A3 (en) Crystalline forms of (3r, 3as, 6ar) - hexahydrofuro [2,3-b] furan-3-yl (1s,2r) - (1-{4-[ (diethoxyphosphoryl) methoxy] pheny1}-3-hydroxy-4- [4-methoxy-n- (2-methylpropyl) benzenesul - fonamido] butan-2-yl) carbamate
BRPI0915541A2 (pt) sulfonas ciclícas com substituição de aminobenzila úteis como inibidores de bace
ES1070020Y (es) Cajon flamenco, instrumento de percusion
ITPD20050097A1 (it) Tappo otoprotettore anatomico per il padiglione auricolare
GB0622748D0 (en) High presure tyres sprial iner & dip stick effect

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: JANSSEN RANDD IRELAND (IE)

B25A Requested transfer of rights approved

Owner name: JANSSEN SCIENCES IRELAND UC (IE)

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B15K Others concerning applications: alteration of classification

Free format text: A CLASSIFICACAO ANTERIOR ERA: C07D 493/04

Ipc: C07D 493/04 (2006.01), A61P 31/18 (2006.01)

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO EM FUNCAO DA REVOGACAO DO ART. 229-C DA LEI NO 9.279, DE 1996, POR FORCA DA LEI NO 14.195, DE 2021

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 01/09/2009, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.